Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by TheTerminator1on Sep 01, 2021 7:54am
92 Views
Post# 33793169

RE:The coronavirus his hear to stay..Get ready for new variants

RE:The coronavirus his hear to stay..Get ready for new variantsThe Coronavirus is here to stay!!! RVV's help will be needed

TheTerminator1 wrote:

Wednesday, September 1

WHAT'S NEW THIS WEEK

 

While hospitals around the United States report oxygen shortages as they treat primarily unvaccinated Americans, a recent University of Washington model said it is possible another 100,000 people could die from Covid-19 by December. 

 

  • That terrifying forecast could be prevented if more Americans get vaccinated, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told CNN Sunday. Around 80 million eligible Americans have still not received the shot and they are the very group who could turn things around, he said. Officials are now urging this unvaccinated group to refrain from traveling over Labor Day as the US averages 160,000 new cases a day

     

  • Children are increasingly in the firing line. More kids in the US were hospitalized with Covid-19 last month than any other time this past year -- proving how seriously the Delta variant can hit any age group. Between August 20 and 26, an average of 330 children were admitted to hospitals every day with Covid-19. Experts say wearing masks in school can help to keep kids safe, and on Monday the Education Department's civil rights enforcement arm announced investigations in five states to determine whether their indoor mask bans were discriminatory against students with disabilities. 

     

  • Two prominent anti-maskers died over the weekend from Covid-19 -- the latest casualties among a string of anti-mask and anti-vaccine crusaders who have died or been hospitalized due to the virus. Florida conservative talk radio show Marc Bernier died on Saturday night. Earlier in the day, prominent mask opponent Caleb Wallace also died after catching Covid-19. He was 30 years old while Bernier was 65.   

     

  • Two senior leaders in the US Food and Drug Administration's (FDA) vaccine review office abruptly resigned as the agency works toward high-profile decisions around Covid-19 vaccine approvals, authorizations for younger children, and the rollout of booster shots. But the booster plan, which starts in late September, requires authorization from the FDA and Centers for Disease Control and Prevention (CDC) first. A source familiar with the situation told CNN there are concerns within the FDA that the White House is getting ahead of where the science is and "prejudging" what the FDA will say when it evaluates the need for boosters.     

     

  • As Western countries prepare to rollout Covid-19 vaccine boosters, a troubling new variant, C.1.2, has popped up across South Africa and seven other countries in Africa, Asia and the Pacific, say researchers. While they are unsure if its constellation of mutations will make it more dangerous, it carries changes that have given other variants increased transmissibility and the ability to evade the immune system's response to some degree. This comes weeks after the World Health Organization warned that if manufacturers prioritize supply for booster shots in richer nations, it will lead to further vaccine inequity and offer opportunities for the virus to mutate in the rest of the world.  

       

  • Two people have died in Japan days after receiving doses from a batch of Moderna Covid-19 vaccines whose use was suspended last week following concerns over a contamination risk, the country's Ministry of Health, Labor and Welfare said Saturday. A causal link between the vaccine and the deaths has not yet been established, according to the ministry and Takeda Pharmaceutical Company, which distributes the Moderna vaccine in Japan.  




<< Previous
Bullboard Posts
Next >>